Stoke Therapeutics, Inc. (STOK): SCHEDULE 13D/A filed Dec 27, 2024

Form type

SCHEDULE 13D/A

Filing date

Dec 27, 2024

Accession number

0001123292-24-000417

Filer

Stoke Therapeutics, Inc. (CIK 1623526)